Healio#health
FDA approves Ziihera combinations for gastroesophageal adenocarcinomatranslating…
Factuality: 74/100USAHealio (SLACK Incorporated)
The FDA approved two zanidatamab-hrii-based regimens as first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma.